This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gho, J. W-M. Articles by Wong, N. Search for Related Content PubMed PubMed Citation Articles by Gho, J. W-M. Articles by Wong, N.

Re-Expression of Transcription Factor ATF5 in Hepatocellular Carcinoma Induces G₂-M Arrest

¹ Li Ka-Shing Institute of Health Sciences, Departments of ² Anatomical and Cellular Pathology and ³ Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong, China

Requests for reprints: Nathalie Wong, Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., SAR Hong Kong, China. Phone: 852-2632-1128; Fax: 852-2637-6274; E-mail: natwong{at}cuhk.edu.hk.

Key Words: hepatocellular carcinoma • 19q13 • transcriptional mapping • ATF5 • G₂-M arrest

Transcription factors represent an important class of genes that play key roles in controlling cellular proliferation, cell cycle modulation, and attractive targets for cancer therapy. Here, we report on the novel finding of common ATF5 down-regulations in hepatocellular carcinoma (HCC), a highly malignant tumor with a dismal clinical course. Array-based mapping in HCC highlighted a high and consistent incidence of transcription factor ATF5 repressions on regional chr.19q13. By quantitative reverse transcription-PCR, profound down-regulations of ATF5 were further suggested in 78% of HCC tumors (60 of 77 cases) compared to their adjacent nontumoral liver (P = 0.0004). Restoration of ATF5 expression in 3 nonexpressing HCC cell lines demonstrated a consistent growth inhibitory effect (P < 0.029) but minimal induction on cellular apoptosis. Subsequent flow cytometric investigations revealed a G₂-M cell cycle arrest in HCC cells that were ectopically transfected with ATF5 (P < 0.002). The differential expressed genes from the functional effects of ATF5 were examined by array profiling. Over a hundred genes were identified, among which ID1 contains the ATF/CREB target binding sequences within its promoter region. An inverse relationship between ATF5 expressions with ID1 transcriptions was verified in HCC (P = 0.019), and a direct interaction of ATF5 on the promoter of ID1 was further demonstrated from electromobility shift assay. Examination of causal events underlying the silencing of ATF5 in HCC suggested copy number losses, promoter hypermethylation, histone deacetylation, and DNA mutations to be the likely inactivating mechanisms. In conclusion, our finding supports a tumor suppressive role for ATF5 in HCC, and highlighted ID1 as a potential downstream target. [Cancer Res 2008;68(16):6743–51]

This article has been cited by other articles:

				G. Li, W. Li, J. M. Angelastro, L. A. Greene, and D. X. Liu Identification of a Novel DNA Binding Site and a Transcriptional Target for Activating Transcription Factor 5 in C6 Glioma and MCF-7 Breast Cancer Cells Mol. Cancer Res., June 1, 2009; 7(6): 933 - 943. [Abstract] [Full Text] [PDF]